131 related articles for article (PubMed ID: 35644422)
1. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
Banks TE; Rajapaksha M; Zhang LH; Bai F; Wang NP; Zhao ZQ
Eur J Pharmacol; 2022 Jul; 927():175048. PubMed ID: 35644422
[TBL] [Abstract][Full Text] [Related]
2. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
[TBL] [Abstract][Full Text] [Related]
3. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.
Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ
Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859
[TBL] [Abstract][Full Text] [Related]
4. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
5. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL
Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.
Zheng RH; Bai XJ; Zhang WW; Wang J; Bai F; Yan CP; James EA; Bose HS; Wang NP; Zhao ZQ
Drug Des Devel Ther; 2019; 13():2745-2757. PubMed ID: 31496651
[TBL] [Abstract][Full Text] [Related]
7. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
8. Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.
Huang Y; Li Y; Lou A; Wang GZ; Hu Y; Zhang Y; Huang W; Wang J; Li Y; Zhu X; Chen T; Lin J; Meng Y; Li X
Clin Sci (Lond); 2020 Apr; 134(7):853-869. PubMed ID: 32227122
[TBL] [Abstract][Full Text] [Related]
9. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
[TBL] [Abstract][Full Text] [Related]
10. Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species.
Lee DY; Wauquier F; Eid AA; Roman LJ; Ghosh-Choudhury G; Khazim K; Block K; Gorin Y
J Biol Chem; 2013 Oct; 288(40):28668-86. PubMed ID: 23940049
[TBL] [Abstract][Full Text] [Related]
11. Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension.
Kang Y; Ding L; Dai H; Wang F; Zhou H; Gao Q; Xiong X; Zhang F; Song T; Yuan Y; Zhu G; Zhou Y
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31466304
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Castoldi G; Carletti R; Ippolito S; Stella A; Zerbini G; Pelucchi S; Zatti G; di Gioia CRT
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948475
[TBL] [Abstract][Full Text] [Related]
13. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.
Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ
Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Chen P; Yang F; Wang W; Li X; Liu D; Zhang Y; Yin G; Lv F; Guo Z; Mehta JL; Wang X
J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):179-188. PubMed ID: 32686479
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II.
Wang NP; Erskine J; Zhang WW; Zheng RH; Zhang LH; Duron G; Gendreau J; Zhao ZQ
J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317706653. PubMed ID: 28490219
[TBL] [Abstract][Full Text] [Related]
19. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
[TBL] [Abstract][Full Text] [Related]
20. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
